Evidence map›Paper›PMID 24717974›Full record

ArticleRNA (New York, N.Y.)2014

A TALEN-based strategy for efficient bi-allelic miRNA ablation in human cells.

Claudia Uhde-Stone, Nandita Sarkar, Travis Antes, Nicole Otoc, Young Kim, Yan J Jiang, Biao Lu

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Claudia Uhde-StoneDepartment of Biological Sciences, California State University, East Bay, Hayward, California 94542, USA.
Nandita SarkarSystem Biosciences (SBI), Mountain View, California 94043, USA.
Travis AntesSystem Biosciences (SBI), Mountain View, California 94043, USA.
Nicole OtocSystem Biosciences (SBI), Mountain View, California 94043, USA.
Young KimSystem Biosciences (SBI), Mountain View, California 94043, USA.
Yan J JiangEndocrine Research Unit, Veterans Affairs Medical Center, Department of Medicine, University of California at San Francisco, San Francisco, California 94121, USA.
Biao LuSystem Biosciences (SBI), Mountain View, California 94043, USA.
System Biosciences (United States) · USCalifornia State University, East Bay · USSan Francisco VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant progress in the functional understanding of microRNAs (miRNAs) has been made in mice, but a need remains to develop efficient tools for bi-allelic knockouts of miRNA in the human genome. Transcription activator-like effector nucleases (TALENs) provide an exciting platform for targeted gene ablation in cultured human cells, but bi-allelic modifications induced by TALENs alone occur at low frequency, making screening for double knockouts a tedious task. Here, we present an approach that is highly efficient in bi-allelic miRNA ablation in the human genome by combining TALENs targeting to the miRNA seed region with a homologous recombination donor vector and a positive selection strategy. A pilot test of this approach demonstrates bi-allelic miR-21 gene disruption at high frequency (∼87%) in cultured HEK293 cells. Analysis of three independent clones showed a total loss of miR-21 expression. Phenotypical analysis revealed increased miR-21 target gene expression, reduced cell proliferation, and alterations of global miRNA expression profiles. Taken together, our study reveals a feasible and efficient approach for bi-allelic miRNA ablation in cultured human cells and demonstrates its usefulness in elucidating miRNA function in human cells.

Indexed as

AllelesCell ProliferationEsterasesGene Knockout TechniquesGene TargetingGenetic VectorsGenome, HumanHEK293 CellsHumansMicroRNAsPilot ProjectsTranscriptional ActivationTranscriptomeEsterasesMicroRNAsMIRN21 microRNA, humandouble knockoutgene-editinghomology-directed repair (HDR)microRNAtranscription activator-like effector nucleases (TALENs)

Identifiers

PMID24717974
PMCPMC4024647
OpenAlexW2147537280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.